Submit Deal

REGENERON

HQ - Tarrytown, NY

Summary

Regeneron Pharmaceuticals is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.

Deals Overview

Total Deals8

Valued Deals8

Total Value£ 5.86 B

Avg. Deal Size£ 733 M

Market Context

Senior Management

Robert Landry
CFO
Robert E. Landry
CFO
George D. Yancopoulos
Board co-Chair, Chief Scientific Officer and President

Sort

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 3.99 B

Total Value

wachtell lipton rosen & katz

HQ - New York

legal advisors (4)

4 Shared Deals

4 For

£ 4.54 B

Total Value

weil gotshal and manges

HQ - New York

legal advisors (1)

1 Shared Deal

1 Along

£ 3.99 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Along

£ 3.99 B

Total Value

fried frank harris shriver & jacobson

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 Opposite

£ 192 M

Total Value

centerview partners

HQ - New York

financial advisors (2)

2 Shared Deals

2 Opposite

£ 359 M

Total Value

macdougall

pr advisors (1)

1 Shared Deal

1 Opposite

£ 192 M

Total Value

goodwin procter

HQ - Boston

legal advisors (2)

2 Shared Deals

2 Opposite

£ 385 M

Total Value

precision aq

HQ - New York

pr advisors (2)

2 Shared Deals

2 Opposite

£ 270 M

Total Value

wilmerhale

HQ - Boston, United States

legal advisors (1)

1 Shared Deal

1 Opposite

£ 167 M

Total Value

ten bridge communications

HQ - Boston

pr advisors (1)

1 Shared Deal

1 Opposite

£ 167 M

Total Value

leerink partners

HQ - Boston, MA, United States

financial advisors (1)

1 Shared Deal

1 Opposite

£ 167 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy